Sentences with phrase «by studying patient»

Gets patients to correct location by studying patient service schedules; planning movement schedules; responding to special requests; designing and improving response systems.

Rao, together with senior author Michael Brenner, set out to explore these questions by studying patient samples in remarkable detail not achieved in earlier studies.

Medical sleuthing, O'Rahilly says, works best by studying patients who seem to defy all sorts of standard diagnoses: «I study the experiments of nature to illuminate the normal.»

«This is a very exciting finding, obtained by studying patients» cells, that has the potential to result in a new treatment for this chronic complication of longstanding Type 1 diabetes,» Dr. Folli said.

«While neuroimaging studies can tell us a great deal about the brain's response to complex events, it's only by studying patients with brain injury that we can see if a brain region is actually needed to perform a given task,» said Dr Clark.

By studying these patients, neurologists have traced the phenomenon to the temporal lobe and its surroundings.

By studying patients who emerge into consciousness after years in limbo, Schiff and Giacino have shown that the brain can sometimes fix itself even decades after damage.

«By studying the patients» heart cells in a dish, we were able to figure out why their hearts were not pumping properly,» explained Srivastava.

(He's demonstrated this difference by studying patients with severed spinal cords: Even when these women had no sensation in their clitoris, they could still experience pleasure — and orgasm — through vaginal stimulation.)

Not exact matches

«From 2012 to 2015, the absolute number of patients treated with nitroprusside decreased by 53 %, and the number treated with isoproterenol decreased by 35 %,» wrote the study authors.

A new study published in the New England Journal of Medicine finds that Valeant Pharmaceuticals» infamous price hikes for a pair of heart drugs called nitroprusside and isoproterenol — whose prices were increased by 310 % and 720 %, respectively — had significant downstream effects on patient care.

GOOGLE»S AI HELPS TO PREDICT CARDIOVASCULAR CONDITIONS BY ANALYZING EYE SCANS: Google and Verily — Google - parent Alphabet's life sciences unit — are exploring new ways that artificial intelligence (AI) can be used to identify patients» risk of suffering from a cardiovascular event, such as a heart attack or stroke, according to a newly published study by the two Alphabet subsidiarieBY ANALYZING EYE SCANS: Google and Verily — Google - parent Alphabet's life sciences unit — are exploring new ways that artificial intelligence (AI) can be used to identify patients» risk of suffering from a cardiovascular event, such as a heart attack or stroke, according to a newly published study by the two Alphabet subsidiarieby the two Alphabet subsidiaries.

After that, Watson will take assist by providing both physician and patient with a report that includes the most relevant drug trial and academic studies for their specific conditions.

The first step in the process is to surgically remove the patient's tumor and ensure that the patient is cancer free by confirming that there is no sign of cancer on blood tests and imaging studies.

Other studies, meanwhile, are examining tryp's potential efficacy as an antifungal agent; and as a prognostic indicator in patients with brain cancer (as seen by increased uptake of the amino acid on a PET scan).

A sleep study conducted by Dr. Marcel Hungs on patients with chronic back pain using Celliant found the median time patients spent awake after falling asleep was reduced by 18.3 minutes.

The study, by Yusuke Tsugawa and colleagues at the Harvard T. H. Chan School of Public Health, Harvard Medical School, and other institutions, examined the record of a large random sample of Medicare patients, 65 years or older, who were hospitalized from January 2011 to December 2014.

An early, outsourced clinical research study with real patients was encouraging, but there are many potential pitfalls yet to come, said University of North Carolina diabetes researcher Dr. John Buse, who was briefed by Google on the lens last week.

But the study also suggested that some antidepressants were more effective than others; several older antidepressants were found to be more effectivee than more modern ones, but the modern treatments (such as Prozac) were better tolerated by patients.

And, the study notes, this can't just be explained away by the fact that it may be used on more «severely ill» patients.

Final patient visits will be followed by completing data entry for the more than 35,000 patient years of study in REDUCE - IT, and typical database quality control measures, known as cleaning.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Nearly a third of patients say that confusion over how much insurance will cover versus patient responsibility contributes to payment delays, according to a West study cited by Televox.

Presentations will highlight the short and long - term effects of Ingrezza on tardive dyskinesia symptoms by body region, long term safety and efficacy data from the KINECT 4 phase 3 open label study and also from RE-KINECT (real - world screening study of patients with possible TD).

For example, Eli Lilly & Co. (NYSE: LLY) has a phase 3 study of solanezumab under way in mild to moderate Alzheimer's disease patients that may slow disease progression by breaking up amyloid plaque buildups thought to be a major cause of the disease.

In a study, conducted by a faith - based group no less, it was shown that ICU patients who knew they were being prayed for tended to suffer more complications and problems than those who were not or did not know.

The idea — and it is all the rage — is that our ubiquitous medical studies will be able to show the cost controllers which procedures work best, and which least, which prophylactic medications work, and which don't, etc. — so that money isn't wasted by doctors and patients pursuing the wrong paths.

The abandoning ethic of assisted suicide is demonstrated by studies showing depression in many patients requesting hastened death.

Traditional Buddhist stories abound of meditators being taken over by evil spirits, and contemporary psychological studies of mindfulness practice going back to the 1970s include patients who experienced hallucinations, psychotic episodes, depression and other mental trauma, as well as nerve pain and similar physical impacts.

A criticism of Byrd's study, which also applies to most other studies, is based on the fact that he did not limit prayers by the friends and family of patients, hence it is unclear which prayers may have been measured, if any.

Here are some parts you left out: - A criticism of Byrd's study, which also applies to most other studies, is based on the fact that he did not limit prayers by the friends and family of patients, hence it is unclear which prayers may have been measured, if any

«A 1999 follow - up by William S Harris et al. attempted to replicate Byrd's findings under stricter experimental conditions, noting that the original research was not completely blinded and was limited to only «prayer - receptive» individuals (57 of the 450 patients invited to participate in the study refused to give consent «for personal reasons or religious convictions»).

As Gawande notes, a study conducted by Aetna Insurance permitting «concurrent care» — having access to both hospice and life - extending treatments — saw hospice participation rise from 26 to 70 percent of eligible patients.

A study of the patients visited regularly by the students (compared with a matched control group of other patients) showed that the program had made a significant difference in the general improvement and discharge rate of those visited.

The study echoed this point as some GPs reported feeling frustrated by having little to offer patients with complex problems driven by social and emotional difficulties anything other than pills.

The results, as measured by reasonably careful follow - tip studies, showed that most of the patients made marked improvement.

They did it right, a nice study in the hospital of heart attack patients, those who were and were not prayed for, those who knew they were prayed for, those who did not, those prayed for by family, those who didn't know, and they had strangers pray for them.

Instead we can take another approach as described by Mary Midgley: «There are two points of view — inside and outside, subjective and objective, the patient's point of view on his toothache and that of the dentist who studies it» (OW 508).

One such study by the University of Utah found that healthy patients who consumed unprocessed cacao experienced a decrease in systolic and diastolic blood pressure by 5 mm within two weeks.

The journals of the American Diabetes Association work toward these goals by publishing high - quality and timely peer - reviewed diabetes research articles, review articles, case studies, and patient information.

A recent research study conducted by the Sahlgrenska Academy at University of Gothenburg in Gothenburg, Sweden, in collaboration with DuPont Nutrition & Health (DuPont), yielded breakthrough results demonstrating that probiotic intervention can alter and modify intestinal microbiota in patients with colon cancer.

A first of its kind pilot study titled, «The Celiac Patient Antibody Response to Conventional and Gluten - Removed Beer,» was published online by the Journal of AOAC International, and was conducted by GIG at the University of Chicago's Celiac Research Center.

In a new study commissioned by The March of Dimes Foundation and published in Fertility and Sterility, researchers from The Hastings Center and Yale Fertility Center examined the practical circumstances of infertility treatment in the US that influence patients and their doctors to make treatment choices that too frequently result in multiple births.

He points to research by a Stanford University researcher, Allan K. Mishra, who has studied PRP for years, whose in his most recent published research includes a large multicenter study [8] involving a host of well - respected orthopedic surgeons around the country who followed 230 patients in a double - blind randomized control study [the gold standard for medical research].

Ironically, the above study demonstrated that 3.7 % of hospitalized patients sustain an injury caused by medical treatment; 69 % of these injuries were preventable and 14 % of these errors contributed to the death of the patient.

There is a particular focus on traditional foods as eaten all over the world by people for thousands of years, as studied by Dr. Weston A. Price in the 1930s during his research in traveling all over the world to determine the cause of degenerative illness in his patients.

Dr. Frederick Leickly, an allergist, writes in his blog about a study published in the Journal of Allergy and Clinical Immunology (JACI) which concluded that a sensitization to fenugreek was believed to have been caused by a peanut allergy in patients.

The related study formed part of a project funded by the National Institute for Health Research Research for Patient Benefit Programme through grant PB - PG -0107-12209.

For the purposes of this economic evaluation, the forms were initially used in a related study funded by the National Institute of Health Research (NIHR) research for patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity care in an inner city area,» which will be reported in full elsewhere, comparing the costs of care in a free standing midwifery unit with care in an obstetric unit in the same trust.16 The data collected included details of staffing levels, treatments, surgeries, diagnostic imaging tests, scans, drugs, and other resource inputs associated with each stage of the pathway through intrapartum and after birth care.

Additional information requested from the study group included position of breast scar, implant volume, and whether loss of nipple sensation had occurred after the surgery (as judged by the patient).